Mediator Kinase Inhibition Impedes Transcriptional Plasticity and Prevents Resistance to ERK/MAPK-Targeted Therapy in KRAS-Mutant Cancers.
Publication
, Preprint
Wood, K; Nussbaum, D; Martz, C; Waters, A; Barrera, A; Rutter, J; Cerda-Smith, C; Stewart, A; Wu, C; Cakir, M; Levandowski, C; Kantrowitz, D ...
November 2, 2023
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Wood, K., Nussbaum, D., Martz, C., Waters, A., Barrera, A., Rutter, J., … Taatjes, D. (2023). Mediator Kinase Inhibition Impedes Transcriptional Plasticity and Prevents Resistance to ERK/MAPK-Targeted Therapy in KRAS-Mutant Cancers. https://doi.org/10.21203/rs.3.rs-3511242/v1
Wood, Kris, Daniel Nussbaum, Colin Martz, Andrew Waters, Alejandro Barrera, Justine Rutter, Christian Cerda-Smith, et al. “Mediator Kinase Inhibition Impedes Transcriptional Plasticity and Prevents Resistance to ERK/MAPK-Targeted Therapy in KRAS-Mutant Cancers.,” November 2, 2023. https://doi.org/10.21203/rs.3.rs-3511242/v1.
Wood K, Nussbaum D, Martz C, Waters A, Barrera A, Rutter J, et al. Mediator Kinase Inhibition Impedes Transcriptional Plasticity and Prevents Resistance to ERK/MAPK-Targeted Therapy in KRAS-Mutant Cancers. 2023.
Wood, Kris, et al. Mediator Kinase Inhibition Impedes Transcriptional Plasticity and Prevents Resistance to ERK/MAPK-Targeted Therapy in KRAS-Mutant Cancers. 2 Nov. 2023. Pubmed, doi:10.21203/rs.3.rs-3511242/v1.
Wood K, Nussbaum D, Martz C, Waters A, Barrera A, Rutter J, Cerda-Smith C, Stewart A, Wu C, Cakir M, Levandowski C, Kantrowitz D, McCall S, Pierobon M, Petricoin E, Smith J, Der C, Taatjes D. Mediator Kinase Inhibition Impedes Transcriptional Plasticity and Prevents Resistance to ERK/MAPK-Targeted Therapy in KRAS-Mutant Cancers. 2023.